Key statistics
On Thursday, Design Therapeutics Inc (DSGN:NSQ) closed at 5.58, -28.25% below its 52-week high of 7.77, set on Nov 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.57 |
---|---|
High | 5.73 |
Low | 5.43 |
Bid | 2.23 |
Offer | 8.85 |
Previous close | 5.48 |
Average volume | 197.32k |
---|---|
Shares outstanding | 56.62m |
Free float | 35.98m |
P/E (TTM) | -- |
Market cap | 315.38m USD |
EPS (TTM) | -0.8465 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 20:59 GMT.
More ▼
- Design Therapeutics to Participate in Multiple Upcoming Investor Conferences
- Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM Portfolio
- Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
- Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio
- Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
- Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
- Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
- Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
More ▼